SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-18-062416
Filing Date
2018-11-30
Accepted
2018-11-29 19:46:23
Documents
7
Period of Report
2018-11-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv507897_8k.htm 8-K 22077
2 EXHIBIT 10.1 tv507897_ex10-1.htm EX-10.1 96674
3 EXHIBIT 10.2 tv507897_ex10-2.htm EX-10.2 6991
4 EXHIBIT 10.3 tv507897_ex10-3.htm EX-10.3 58755
5 EXHIBIT 99.1 tv507897_ex99-1.htm EX-99.1 11018
6 GRAPHIC image_001.jpg GRAPHIC 20242
7 GRAPHIC image_002.jpg GRAPHIC 20242
  Complete submission text file 0001144204-18-062416.txt   253103
Mailing Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219
Business Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219 2149055100
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15771 | Film No.: 181209612
SIC: 2834 Pharmaceutical Preparations